1. Home
  2. LRCX vs NVO Comparison

LRCX vs NVO Comparison

Compare LRCX & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lam Research Corporation

LRCX

Lam Research Corporation

HOLD

Current Price

$222.67

Market Cap

206.9B

Sector

Technology

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$62.02

Market Cap

212.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRCX
NVO
Founded
1980
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.9B
212.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LRCX
NVO
Price
$222.67
$62.02
Analyst Decision
Strong Buy
Hold
Analyst Count
25
10
Target Price
$186.08
$54.25
AVG Volume (30 Days)
12.9M
20.8M
Earning Date
01-28-2026
02-04-2026
Dividend Yield
0.47%
1.97%
EPS Growth
46.65
10.06
EPS
4.53
3.67
Revenue
$19,591,788,000.00
$49,580,393,058.00
Revenue This Year
$17.52
$7.25
Revenue Next Year
$14.43
$0.24
P/E Ratio
$49.21
$16.45
Revenue Growth
25.66
16.64
52 Week Low
$56.32
$43.08
52 Week High
$229.57
$93.80

Technical Indicators

Market Signals
Indicator
LRCX
NVO
Relative Strength Index (RSI) 71.40 72.64
Support Level $206.61 $56.29
Resistance Level $229.57 $60.63
Average True Range (ATR) 7.95 1.44
MACD 2.24 0.59
Stochastic Oscillator 88.13 96.28

Price Performance

Historical Comparison
LRCX
NVO

About LRCX Lam Research Corporation

Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: